ETON Pharmaceuticals (NASDAQ: ETON) net income
ETON Pharmaceuticals reported a net loss of $4.6m for fiscal 2025; in fiscal 2024 it reported a net loss of $3.8m. Earnings per share were −$0.17.
ETON Pharmaceuticals's best year of the last 8 was fiscal 2023. It reported a loss in 8 of those 8 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | −$4.6m | — | −5.8% | −$0.17 |
| 2024 | −$3.8m | — | −9.8% | −$0.15 |
| 2023 | −$0.9m | — | −3.0% | −$0.04 |
| 2022 | −$9.0m | — | −42.4% | −$0.36 |
| 2021 | −$2.0m | — | −9.0% | −$0.08 |
| 2020 | −$28.0m | — | −71,717.9% | −$1.33 |
| 2019 | −$18.3m | — | −1,910.3% | — |
| 2018 | −$12.7m | — | — | — |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
ETON Pharmaceuticals net income compared with its sector
By net income for its latest fiscal year, ETON Pharmaceuticals ranks 181st of the 501 US health care companies with a page on Celsmar. The sector median net margin is −6.2%; that of ETON Pharmaceuticals, −5.8%.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 179th | Omeros | −$3.4m | — |
| 180th | BioLife Solutions | −$4.6m | −4.8% |
| 181st | ETON Pharmaceuticals | −$4.6m | −5.8% |
| 182nd | Harrow | −$5.1m | −1.9% |
| 183rd | Akebia Therapeutics | −$5.3m | −2.3% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of ETON Pharmaceuticals
- How much did ETON Pharmaceuticals earn in fiscal 2025?
- ETON Pharmaceuticals reported a net loss of $4.6m for fiscal 2025. In fiscal 2024 it reported a net loss of $3.8m.
- What are the earnings per share of ETON Pharmaceuticals?
- They were −$0.17 in fiscal 2025, compared with −$0.15 in fiscal 2024.
- Where does ETON Pharmaceuticals rank in its sector by net income?
- It ranks 181st of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for ETON Pharmaceuticals come from?
- From the annual report (Form 10-K) that ETON Pharmaceuticals files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that ETON Pharmaceuticals files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018. More on ETON Pharmaceuticals: the ETON Pharmaceuticals page · annual accounts · revenue · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.